638 related articles for article (PubMed ID: 22917622)
1. Examining the role of endogenous orexins in hypothalamus-pituitary-adrenal axis endocrine function using transient dual orexin receptor antagonism in the rat.
Steiner MA; Sciarretta C; Brisbare-Roch C; Strasser DS; Studer R; Jenck F
Psychoneuroendocrinology; 2013 Apr; 38(4):560-71. PubMed ID: 22917622
[TBL] [Abstract][Full Text] [Related]
2. Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity.
van Haarst AD; Oitzl MS; Workel JO; de Kloet ER
Endocrinology; 1996 Nov; 137(11):4935-43. PubMed ID: 8895366
[TBL] [Abstract][Full Text] [Related]
3. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
Calogero AE; Scaccianoce S; Burrello N; Nicolai R; Muscolo LA; Kling MA; Angelucci L; D'Agata R
J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244
[TBL] [Abstract][Full Text] [Related]
4. Effects of orexins on the hypothalamic-pituitary-adrenal system.
Jászberényi M; Bujdosó E; Pataki I; Telegdy G
J Neuroendocrinol; 2000 Dec; 12(12):1174-8. PubMed ID: 11106974
[TBL] [Abstract][Full Text] [Related]
5. Novel in vitro perfusion system for the determination of hypothalamic-pituitary-adrenal axis responses.
Moidel MA; Belz EE; Czambel RK; Rubin RT; Rhodes ME
J Pharmacol Toxicol Methods; 2006; 53(3):264-71. PubMed ID: 16311047
[TBL] [Abstract][Full Text] [Related]
6. Differential responses of hypothalamus-pituitary-adrenal axis immediate early genes to corticosterone and circadian drive.
Girotti M; Weinberg MS; Spencer RL
Endocrinology; 2007 May; 148(5):2542-52. PubMed ID: 17303667
[TBL] [Abstract][Full Text] [Related]
7. Impaired release of corticosterone from adrenals contributes to impairment of circadian rhythms of activity in hyperammonemic rats.
Llansola M; Ahabrach H; Errami M; Cabrera-Pastor A; Addaoudi K; Felipo V
Arch Biochem Biophys; 2013 Aug; 536(2):164-70. PubMed ID: 23376587
[TBL] [Abstract][Full Text] [Related]
8. Orexins in the regulation of the hypothalamic-pituitary-adrenal axis.
Spinazzi R; Andreis PG; Rossi GP; Nussdorfer GG
Pharmacol Rev; 2006 Mar; 58(1):46-57. PubMed ID: 16507882
[TBL] [Abstract][Full Text] [Related]
9. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis.
Swain MG; Patchev V; Vergalla J; Chrousos G; Jones EA
J Clin Invest; 1993 May; 91(5):1903-8. PubMed ID: 8387536
[TBL] [Abstract][Full Text] [Related]
10. Corticosterone, brain mineralocorticoid receptors (MRs) and the activity of the hypothalamic-pituitary-adrenal (HPA) axis: the Lewis rat as an example of increased central MR capacity and a hyporesponsive HPA axis.
Oitzl MS; van Haarst AD; Sutanto W; de Kloet ER
Psychoneuroendocrinology; 1995; 20(6):655-75. PubMed ID: 8584606
[TBL] [Abstract][Full Text] [Related]
11. Food deprivation differentially modulates orexin receptor expression and signaling in rat hypothalamus and adrenal cortex.
Karteris E; Machado RJ; Chen J; Zervou S; Hillhouse EW; Randeva HS
Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1089-100. PubMed ID: 15687100
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide mediates the interleukin-1beta- and nicotine-induced hypothalamic-pituitary-adrenocortical response during social stress.
Gadek-Michalska A; Bugajski J
J Physiol Pharmacol; 2005 Sep; 56(3):491-503. PubMed ID: 16204770
[TBL] [Abstract][Full Text] [Related]
13. The muscarinic cholinergic agonist arecoline stimulates the rat hypothalamic-pituitary-adrenal axis through a centrally-mediated corticotropin-releasing hormone-dependent mechanism.
Calogero AE; Kamilaris TC; Gomez MT; Johnson EO; Tartaglia ME; Gold PW; Chrousos GP
Endocrinology; 1989 Nov; 125(5):2445-53. PubMed ID: 2551652
[TBL] [Abstract][Full Text] [Related]
14. The central effects of orexin-A in the hypothalamic-pituitary-adrenal axis in vivo and in vitro in male rats.
Russell SH; Small CJ; Dakin CL; Abbott CR; Morgan DG; Ghatei MA; Bloom SR
J Neuroendocrinol; 2001 Jun; 13(6):561-6. PubMed ID: 11412343
[TBL] [Abstract][Full Text] [Related]
15. The nociceptin/orphanin FQ antagonist UFP-101 differentially modulates the glucocorticoid response to restraint stress in rats during the peak and nadir phases of the hypothalamo-pituitary-adrenal axis circadian rhythm.
Leggett JD; Jessop DS; Fulford AJ
Neuroscience; 2007 Jul; 147(3):757-64. PubMed ID: 17574767
[TBL] [Abstract][Full Text] [Related]
16. Intracerebroventricular administration of corticotrophin-releasing hormone receptor antagonists produces different effects on hypothalamic pituitary adrenal responses to novel restraint depending on the stress history of the animal.
Vining C; Iyer V; Bhatnagar S
J Neuroendocrinol; 2007 Mar; 19(3):198-207. PubMed ID: 17280593
[TBL] [Abstract][Full Text] [Related]
17. Orexin in sleep, addiction and more: is the perfect insomnia drug at hand?
Hoyer D; Jacobson LH
Neuropeptides; 2013 Dec; 47(6):477-88. PubMed ID: 24215799
[TBL] [Abstract][Full Text] [Related]
18. A comparison of two repeated restraint stress paradigms on hypothalamic-pituitary-adrenal axis habituation, gonadal status and central neuropeptide expression in adult male rats.
Gray M; Bingham B; Viau V
J Neuroendocrinol; 2010 Feb; 22(2):92-101. PubMed ID: 20002965
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by three selective type-4 phosphodiesterase inhibitors: in vitro and in vivo studies.
Kumari M; Cover PO; Poyser RH; Buckingham JC
Br J Pharmacol; 1997 Jun; 121(3):459-68. PubMed ID: 9179387
[TBL] [Abstract][Full Text] [Related]
20. Central orexin-A activates hypothalamic-pituitary-adrenal axis and stimulates hypothalamic corticotropin releasing factor and arginine vasopressin neurones in conscious rats.
Al-Barazanji KA; Wilson S; Baker J; Jessop DS; Harbuz MS
J Neuroendocrinol; 2001 May; 13(5):421-4. PubMed ID: 11328451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
